Focus Universal Inc. (FCUV) Stock Price & Analysis
Focus Universal Inc. (FCUV) fell 4.60% to USD 0.83 as of June 13, 2026 at 14:50 UTC, according to Nexqual real-time market data.
FCUV last closed at USD 0.87; the session ranged USD 0.78–0.84 on volume of 109,021 shares. Market capitalization is $2.33M, with a 52-week range of USD 0.53–52.5 (NCM). Source: Nexqual, June 13, 2026 at 14:50 UTC.
Key Statistics (as of June 13, 2026 at 14:50 UTC)
| Price | USD 0.83 |
|---|---|
| Change | ▼ 4.60% (down) |
| Previous Close | USD 0.87 |
| Open | USD 0.84 |
| Day Range | USD 0.78 – 0.84 |
| 52-Week Range | USD 0.53 – 52.5 |
| Volume | 109,021 shares |
| Market Cap | $2.33M |
| Exchange | NCM |
Technical Analysis (FCUV)
Nexqual's technical model rates FCUV "SELL" based on 1 bullish and 4 bearish signals across 124 daily candles, as of June 13, 2026 at 14:50 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 39.62 (neutral) |
| vs SMA50 | Below (USD 1.49) |
| MACD | -0.18 (negative) |
Analyst Ratings (FCUV)
Wall Street analysts rate FCUV "None", per Nexqual as of June 13, 2026 at 14:50 UTC.
| Consensus Rating | None |
|---|
Earnings (FCUV)
Source: Nexqual, June 13, 2026 at 14:50 UTC.
Financials & Fundamentals (FCUV)
| Total Revenue | $112,741 |
|---|---|
| Revenue Growth (YoY) | -74.80% |
| Gross Margin | -44.84% |
| Operating Margin | -2650.89% |
| Profit Margin | +0.00% |
| ROE | -104.78% |
| Debt / Equity | 1.56 |
| Current Ratio | 13.36 |
| Total Cash | $6.10M |
| Total Debt | $112,814 |
| Free Cash Flow | $-4.08M |
Source: Nexqual, June 13, 2026 at 14:50 UTC.
Financial Health Score (FCUV)
Nexqual rates Focus Universal Inc.'s overall financial health "Weak" across five dimensions, as of June 13, 2026 at 14:50 UTC.
| Growth | Critical — Revenue -75% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Strong — $6M cash, no debt |
| Cash Flow | Weak — FCF negative: -$4M, burning cash |
| Efficiency | Critical — ROE -105%, ROA -58.5% |
Ownership (FCUV)
| Insider Ownership | +14.43% |
|---|---|
| Institutional Ownership | +0.65% |
| Shares Outstanding | 2.81M |
| Float | 1.75M |
| Short % of Float | +0.83% |
Source: Nexqual, June 13, 2026 at 14:50 UTC.
Leadership (FCUV)
Focus Universal Inc. is led by Desheng Wang (age 61), CEO, Secretary & Director, per Nexqual as of June 13, 2026 at 14:50 UTC.
| CEO, Secretary & Director | Desheng Wang (age 61) |
|---|---|
| CFO & Director | Irving H. Kau (age 51) |
Major Backers & Investors (FCUV)
Notable institutional backers of Focus Universal Inc. include Fidelity, according to Nexqual as of June 13, 2026 at 14:50 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 0.4% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Geode Capital | 0.42% |
| Vanguard Group | 0.25% |
Source: Nexqual, June 13, 2026 at 14:50 UTC.
From Focus Universal Inc.'s Latest SEC 10-K Filing (filed 2026-03-31)
Key Strengths & Strategy (as disclosed to the SEC)
- We intend to commercialize this product under a software as a service (SaaS) model.   Other than our financial reporting software, the technologies, products and services that we have developed, and are currently developing, we believe will have significant applications in the IoT industry.
- These modules will be used for IoT systems involving over 1,000 sensors.   Natural Integrated Programming Language ("NIPL")   We have developed a patented "user interface machine auto generation platform" ("UIMAGP") to replace manual software design.
- To address these challenges, we have segmented our operations and developed the technologies and products described below.   In addition to our universal smart technology and financial reporting software, we are current researching and developing the following:   Device on a Chip   We have developed an innovative "device on a chip" ("DoC") technology, which combines the required electronic circuits of various integrated circuit components onto a single, integrated chip ("IC").
- Comparison between Ultra-Narrowband and Broadband   We developed an ultra-narrowband technology that offers a potential alternative and/or complementary solution to the broadband technology used in 5G networks and meets the challenging 5G demands.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| VRPX | Virpax Pharmaceuticals, Inc. | USD 0 | ▲ 25% |
| INDP | Indaptus Therapeutics, Inc. | USD 3.58 | ▲ 46.12% |
| EFTR | eFFECTOR Therapeutics, Inc. | USD 0 | ▲ 0% |
| AUUD | Auddia Inc. | USD 1.32 | ▲ 2.33% |
| DATS | DatChat, Inc. | USD 2.66 | ▲ 16.96% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 13, 2026 at 14:50 UTC. This page is informational and not investment advice.